| NCT05315115 | Effects of Intensive Chiropractic Care to Usual Care for Adults With Spinal Cord Injuries. | Riphah International University | | - Age 20 - 70 yrs
- Level -
AIS - All
| Ended | 29 | NA | Rehabilitation | Arm/hand function | - American Spinal Injury Association Impairment Scale (AIS): International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI)
- Functional Independence Measure (FIM)
- Short Form 36 (SF-36)
| | 07 April 2022 | 07 April 2022 | 1 | |
| NCT05319522 | The Relationship Between Irisin and Bone Health in Individuals With Spinal Cord Injury | VA Office of Research and Development | | - Age ≥ 18 yrs
- Level C4-S5
AIS A, B, C- ≥ 12 months
- use manual wheelchair as primary means of mobility
| Ended | 11 | NA | Rehabilitation | Bone health | | | 05 May 2023 | 08 April 2022 | 1 | |
| NCT05317832 | Using Smartphones to Improve Physical Activity Levels of Individuals With Spinal Cord Injury | Temple University | | - Age 18 - 75 yrs
- Level C5-S5
AIS - ≥ 6 months
| Recruiting | 196 | PHASE2 | Psychosocial/other | Arm/hand function | - Physical Activity Recall Assessment for People with Spinal Cord injury (PARA-SCI)
| | 25 May 2023 | 08 April 2022 | 1 | |
| NCT05318079 | Telehealth Virtual Reality Exergaming for Spinal Cord Injury | University of Alabama at Birmingham | | - Age ≥ 15 yrs
- Level -
AIS - All
| Ended | 0 | NA | | General health | - World Health Organization Quality of Life- BREF (WHOQOL-BREF)
| | 01 April 2022 | 08 April 2022 | 0 | |
| NCT05334342 | Low-GI Diet Vs High-GI Diet in Individuals with SCI | Ohio State University | | - Age 18 - 65 yrs
- Level C4-L2
AIS A, B, C, D- All
- NOT have diabetes, heart disease, or other neurological impairment
| Ended | 11 | NA | Psychosocial/other | General health | | 3 days | 05 July 2023 | 19 April 2022 | 1 | |
| NCT05101018 | Treatment With Romosozumab Versus Denosumab to Improve Bone Mineral Density and Architecture in Subacute SCI | James J. Peters Veterans Affairs Medical Center | | - Age 18 - 50 yrs
- Level C4-L2
AIS A, B- ≤ 6 months
| Active | 40 | PHASE4 | Drug | Bone health | | | 01 November 2021 | 29 October 2021 | 3 | |
